The next step in organ transplants: New startup takes aim at reperfusion injury

Charleston, SC-based Lydex Pharmaceuticals has received a small business technology transfer grant from the NIH to investigate and develop compounds targeting key enzymes responsible for organ damage, inflammation and rejection after transplant

Read more